Lyra Therapeutics Inc
NASDAQ:LYRA
Lyra Therapeutics Inc
Retained Earnings
Lyra Therapeutics Inc
Retained Earnings Peer Comparison
Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors
Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Lyra Therapeutics Inc
NASDAQ:LYRA
|
Retained Earnings
-$311.4m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Retained Earnings
$153.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Retained Earnings
$15.6B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-7%
|
|
Pfizer Inc
NYSE:PFE
|
Retained Earnings
$121.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Merck & Co Inc
NYSE:MRK
|
Retained Earnings
$56.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Eli Lilly and Co
NYSE:LLY
|
Retained Earnings
$12.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
21%
|
CAGR 10-Years
-3%
|
See Also
What is Lyra Therapeutics Inc's Retained Earnings?
Retained Earnings
-311.4m
USD
Based on the financial report for Dec 31, 2023, Lyra Therapeutics Inc's Retained Earnings amounts to -311.4m USD.
What is Lyra Therapeutics Inc's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-23%
Over the last year, the Retained Earnings growth was -25%. The average annual Retained Earnings growth rates for Lyra Therapeutics Inc have been -28% over the past three years , -23% over the past five years .